Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7382 p3-6
7 January 2006

This section
Reprint   Photocopy

PDF 220K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

3 Restrictions lifted on nicotine replacement therapy Pharmacists have welcomed the announcement that children aged over 12 years and women who are pregnant or breast feeding can now use nicotine replacement therapy (NRT) ...more

3 NRT use in pregnancy increases risk of birth defects, study suggests Using nicotine replacement therapy (NRT) in early pregnancy increases the risk of birth defects, according to data from a study ...more

3 Pharmacists awarded MBEs in Honours list Two pharmacists have been recognised in the New Year Honours list for 2006 ...more

3 Statement on contract monitoring issued In monitoring the new contract, representatives of primary care trusts can enter pharmacy premises and request documents necessary for audit and monitoring purposes. However, contractors are not obliged to send copies of these documents to PCTs, according to the Pharmaceutical Services Negotiating Committee and the Primary Care Contracting team ...more

4 Drug donations cause health and economic problems In an emergency situation, drug donations are useless — they cause additional public health problems for the affected population and economic problems for the country, a report by the humanitarian organisation Pharmaciens Sans Frontières (PSF) concludes ...more

4 Clot risk the same for all modes of transport Travelling for more than four hours in any form of transport increases the risk of venous thromboembolism (VTE), a series of studies funded by the Department of Health, the Department of Transport and the European Commission has shown ...more

4 CHD risk associated with diabetes higher in women Research has revealed that women with diabetes are at higher risk of dying from coronary heart disease than men with diabetes ...more

4 Intensive treatment reduces cardiovascular disease risk in type 1 diabetes Intensive diabetes treatment reduces the long-term risk of cardiovascular disease in patients with type 1 diabetes, new data have confirmed ...more

4 Letrozole reduces breast cancer recurrence rates Compared with tamoxifen, letrozole (Femara; Novartis) significantly reduces the risk of recurrence of hormone-receptor-positive breast cancer in post-menopausal women, new data have shown ...more

5 First guidance for pharmacists published by CfH Guidance on what pharmacy contractors in England need to do in order to implement release 1 of the electronic prescription service (EPS) has been published by NHS Connecting for Health (CfH) ...more

5 Over 6,000 chlamydia test kits issued in Boots pilot More than 6,000 test kits for the sexually transmitted infection chlamydia have been issued by Boots pharmacists in the first month of a pilot scheme in London ...more

5 Draft CD management guidance to be altered Draft guidance on the safer management of Controlled Drugs is to be revised in the light of responses to last year's consultation on the subject ...more

5 Patients get to choose NHS patients in England are now able to choose any one of four places they are offered when referred by GPs for specialist treatment ...more

5 Ketamine controls Ketamine became a Schedule 4 Part 1 Controlled Drug on 1 January ...more

5 Hangover cures No compelling evidence exists to suggest that available interventions are effective at preventing or treating alcohol-induced hangovers, a study has shown ...more

6 Vitamin D could reduce cancer risk Supplementation with 1,000IU of vitamin D3 daily could reduce the incidence of colon, breast, prostate and ovarian cancer, at low cost and with few adverse effects, according to researchers at the Moores Cancer Centre, University of California, San Diego ...more

6 Statins have neutral effect on cancer incidence Statins have a neutral effect on the risk of developing or dying from cancer, conclude the authors of a paper ...more

6 LDL cholesterol lowered by new food product A new cholesterol lowering ingredient, Reducol, is expected to be sold in food products this month. It is a mixture of phytosterols derived from coniferous trees and can be mixed with spreads, yoghurts and other food and drinks ...more

Back to Top


©The Pharmaceutical Journal